Poor nations' high tariffs block access to drugs, report warns
This article was originally published in Scrip
Executive Summary
A number of low and middle-income countries are continuing to impose "punitively high" import tariff rates on pharmaceuticals, which is affecting patients' access to medicines, a new report reveals.